GDX Stock Chart Mon, Jan 13th, 2014

Rosti Bets on Expansion with Alvi Buyout Rosti Group just rolled the dice big by swallowing Alvi Group, marking another bold move in the ever-swinging industrial and medical device manufacturing rodeo. Suddenly, we’re talking about a company with roughly 3,000 employees on its roster and a neat EUR 450 million in combined revenue. Don't overlook the power play...

San Diego's Seasonal Giving: A Community Effort Hold onto your hats, folks—it's that time of the year when giving isn't just a suggestion; it's a full-fledged community rallying cry. Heading into the joyful chaos is North Island Credit Union, teaming up with Boys & Girls Clubs of Greater San Diego to bring the spirit of the season to children across the region. Through...

NextVision's financials this quarter are the envy of tech growth companies everywhere. Their Q3 2026 report reads like a thrilling playbook for success. No half-measures here—NextVision has doubled its revenue, slashed costs, and cooked up an operating margin fit for a kingpin. Pushing Revenue to New Heights NextVision didn’t just surpass last year's revenue; it...

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

A New Power Couple in AI Expedera and Cadence have decided to stir up the edge AI waters with their latest collaboration. By linking Expedera's Origin™ Evolution NPU with Cadence's Tensilica NeuroEdge 130 AI Co-Processor, we're looking at a partnership that's hell-bent on redefining efficiency and performance in edge AI systems. Breaking Down the Collaboration This...

Onodrim Industries' Bold Bid to Reshape European Security Right out of the gate, Onodrim Industries is thundering onto the scene with a hefty $300 million Series A round to flex its muscles across Europe's defence and industrial sectors. This ain't your run-of-the-mill startup story. This is about flexing hard-earned capital to snap up established players and inject a...

Bybit's Bold Foray Into Japanese Equities Isn't every trader just itching to talk about Japan these days? Well, Bybit's got your back with its latest maneuvers. The platform is broadening its scope by diving headfirst into Japanese equities with a fresh offering—JPE backed by JX, no less. Bybit's RWA Earn platform isn't sticking to the boring fixed-income strategy...

Rivada's Outernet: A New Era of Connectivity Forget the terrestrial wires; we're talking about 600 satellites playing a space-age game of telephone. That's Rivada's Outernet for you, an orbital mesh network that's about to upend the very nature of global communications. Telespazio's new partnership with Rivada is like strapping a rocket onto secure connectivity in the...

Turning Heads with a New Approach in Immunotherapy Right off the bat, let's say something's brewing in the world of cancer treatment, and it's got a promising name: BND-67. We're talking about Biond Biologics, an ambitious Israeli outfit aiming to rewrite the rules with their new kid on the block in immunotherapies. This isn't about business as usual. It's about a fresh...

Revolution in Sleep Health The paper has officially announced a promising shift in sleep apnea treatment. Eli Lilly's Foundayo, revealed through a Phase 3 clinical program, is looking to tackle obstructive sleep apnea (OSA) with unprecedented potential. Forget the traditional methods—this small molecule GLP-1 receptor agonist could be a game changer for folks plagued by...

Starwood Property Trust Expands Private Offering of Bonds Starwood Property Trust, Inc. (NYSE: STWD) has made a significant announcement regarding its latest financial maneuver. The company has priced its private offering, which has now been upsized to an impressive $500 million. This offering involves unsecured senior notes with a fixed interest rate of 6.500% due in...

Prime Medicine (NASDAQ: PRME) landed a hefty collaboration with Bristol Myers Squibb (NYSE: BMY) back in 2024, worth a cool $110 million. The breakdown? A sweet $55 million upfront payment paired with another $55 million as an equity investment. Now, this kind of cash infusion had traders buzzing—just what they needed to keep the lights on until at least mid-2026. But...

Truly Hard Seltzer Introduces the Innovative Rain Check Program Summer is a season of joy, sunshine, and outdoor gatherings, but unpredictable weather can put a damper on plans. As we approach July, many anticipate pool parties and barbecues. However, with increased rainfall patterns reported in various regions, July 4th celebrations might not go as planned. To help fans...

Top Cybersecurity Tips for the Holiday Season As the holiday season approaches, it presents a myriad of opportunities for shoppers and cybercriminals alike. KnowBe4, a leader in cybersecurity solutions and training, highlights the need for awareness among consumers. This year, the company announces their top five cybersecurity tips aimed at helping shoppers stay safe and...

Plaza Retail REIT Announces New Leadership Plaza Retail REIT has officially communicated an exciting shift in its leadership structure. Jason Parravano will take over the role of President & CEO, succeeding Michael Zakuta, who will remain actively involved with the Trust as a Trustee. This leadership transition signifies Plaza's commitment to continuing its strategic...